We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » France to Beef Up Clinical Trial Requirements for Flow Diverter Stents
France to Beef Up Clinical Trial Requirements for Flow Diverter Stents
France’s National Agency for the Safety of Medicines (ANSM) is calling for more exhaustive clinical studies prior to CE marking of flow diverter stents that are implanted to treat intracranial aneurysms.